Related references
Note: Only part of the references are listed.Virus-Like Particles as Particulate Vaccines
Luigi Buonaguro et al.
CURRENT HIV RESEARCH (2010)
Viral strategies for the evasion of immunogenic cell death
L. Galluzzi et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Conserved Motifs within Ebola and Marburg Virus VP40 Proteins Are Important for Stability, Localization, and Subsequent Budding of Virus-Like Particles
Yuliang Liu et al.
JOURNAL OF VIROLOGY (2010)
Oligomerization of Ebola Virus VP40 Is Essential for Particle Morphogenesis and Regulation of Viral Transcription
T. Hoenen et al.
JOURNAL OF VIROLOGY (2010)
Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus
Charalampos Valmas et al.
PLOS PATHOGENS (2010)
Disease modeling for Ebola and Marburg viruses
Dennis Bente et al.
DISEASE MODELS & MECHANISMS (2009)
Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever
Kelly L. Warfield et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus
Jonas Naslund et al.
VIROLOGY (2009)
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
Yuliang Sun et al.
VIROLOGY (2009)
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
Dana L. Swenson et al.
EXPERT REVIEW OF VACCINES (2008)
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2008)
Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Mapping of a region of Ebola virus VP40 that is important in the production of virus-like particles
Seiya Yamayoshi et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Lymphocyte death in a mouse model of Ebola virus infection
Steven B. Bradfute et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Role for amino acids 212KLR214 of Ebola virus VP40 in assembly and budding
Sarah E. McCarthy et al.
JOURNAL OF VIROLOGY (2007)
Successful topical respiratory tract immunization of primates against ebola virus
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2007)
Effective post-exposure treatment of Ebola infection
Heinz Feldmann et al.
PLOS PATHOGENS (2007)
Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies
Ling Ye et al.
VIROLOGY (2006)
Ebola virus VP24 binds karyopherin α1 and blocks STAT1 nuclear accumulation
St. Patrick Reid et al.
JOURNAL OF VIROLOGY (2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates:: an efficacy assessment
KM Daddario-DiCaprio et al.
LANCET (2006)
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge
A Bukreyev et al.
JOURNAL OF VIROLOGY (2006)
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF IMMUNOLOGY (2005)
Analysis of Ebola virus and VLP release using an immunocapture assay
G Kallstrom et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
DL Swenson et al.
VACCINE (2005)
Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages
V Wahl-Jensen et al.
JOURNAL OF VIROLOGY (2005)
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
M Garbutt et al.
JOURNAL OF VIROLOGY (2004)
The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes:: Exploiting the retrograde late endosomal pathway
L Kolesnikova et al.
JOURNAL OF VIROLOGY (2004)
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein
DL Swenson et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2004)
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
KL Warfield et al.
VACCINE (2004)
Ebola and Marburg virus-like particles activate human myeloid dendritic cells
CM Bosio et al.
VIROLOGY (2004)
Role of natural killer cells in innate protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles
JM Licata et al.
JOURNAL OF VIROLOGY (2004)
In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding
RG Panchal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation
CM Bosio et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Pathogenesis of Ebola hemorrhagic fever in primate models - Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
J Riemenschneider et al.
VACCINE (2003)
Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers
CO Tacket et al.
CLINICAL IMMUNOLOGY (2003)
Virus-like particles as immunogens
R Noad et al.
TRENDS IN MICROBIOLOGY (2003)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3
CF Basler et al.
JOURNAL OF VIROLOGY (2003)
Vaccine research efforts for filoviruses
MK Hart
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs
JL Mellquist-Riemenschneider et al.
VIRUS RESEARCH (2003)
Impairment of dendritic cells and adaptive immunity by Ebola and lassa viruses
S Mahanty et al.
JOURNAL OF IMMUNOLOGY (2003)
Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4
J Timmins et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: Involvement of host proteins TSG101 and VPS-4
JM Licata et al.
JOURNAL OF VIROLOGY (2003)
Biochemical and functional characterization of the Ebola virus VP24 protein: Implications for a role in virus assembly and budding
ZY Han et al.
JOURNAL OF VIROLOGY (2003)
Induction of immune responses in mice and monkeys to ebola virus after immunization with liposome-encapsulated irradiated ebola virus:: Protection in mice requires CD4+ T cells
M Rao et al.
JOURNAL OF VIROLOGY (2002)
Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP
T Noda et al.
JOURNAL OF VIROLOGY (2002)
Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses
S Bavari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment
L Kolesnikova et al.
JOURNAL OF VIROLOGY (2002)
Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses
P Pushko et al.
JOURNAL OF VIROLOGY (2001)
Marburg virus vaccines: comparing classical and new approaches
M Hevey et al.
VACCINE (2001)
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21
DC Waite et al.
VACCINE (2001)
Ebola virus VP40-induced particle formation and association with the lipid bilayer
LD Jasenosky et al.
JOURNAL OF VIROLOGY (2001)
Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein
JA Wilson et al.
JOURNAL OF VIROLOGY (2001)
A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding
RN Harty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
P Pushko et al.
VACCINE (2000)
Structural characterization and membrane binding properties of the matrix protein VP40 of Ebola virus
RWH Ruigrok et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Crystallization and preliminary X-ray analysis of the matrix protein from Ebola virus
A Dessen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2000)
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
S Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses
TW Geisbert et al.
LABORATORY INVESTIGATION (2000)
Share Paper
